UH3DE029169
Cooperative Agreement
Overview
Grant Description
Phase II, Proof-of-Concept Randomized Controlled Trial to Evaluate Dental Caries Preventive Effects of Fluoridated Bottle Water
The dental health benefits of fluoride in drinking water have never been tested in a randomized controlled trial (RCT). Instead, the addition of fluoride to many public water systems during the 20th century and the defense against fluoridation's critics were justified based on results from observational studies and a few non-randomized, community intervention studies. However, the growth in fluoridated public water systems has stalled, leaving 100 million Americans living in places without fluoridated water, which is unlikely to change.
Another issue is that nationwide, 15% of children do not drink tap water for various reasons, including consumer preference and distrust of public water. One potential solution is to increase the consumption of fluoridated bottled water, capitalizing on consumers' demand for it. However, for public health to embrace this strategy as an extension of fluoridation, there needs to be RCT evidence of the dental health benefits of fluoridated bottled water.
Given the absence of a precedent and uncertainty regarding compliance and the likely effect size of the intervention, a fully powered RCT is premature. Instead, we propose a Phase II, proof-of-concept RCT to evaluate the dental caries preventive effects of fluoridated bottled water in a community not served by water fluoridation. The primary recruitment population will be approximately 470 babies born during a one-year period in Kinston, NC, which has the largest non-fluoridated public water system in the state and where caries prevalence exceeds the state average.
In households where the measured content of fluoride in tap water is less than 0.2 ppm, we will randomize 200 infant/family dyads in a 1:1 ratio to receive either fluoridated or non-fluoridated bottled water. The two types of commercially available water in 5-gallon bottles will be relabeled to mask the fluoride content from infants, families, and researchers. For 3½ years after randomization, each household will be provided with water, dispensers, and other supplies to encourage water consumption consistent with nutritional recommendations. Bottled water consumption will be monitored, and fingernail clippings will be collected to provide a biomarker measure of fluoride intake.
A dental examination conducted when children are aged 48-53 months will measure caries experience using the index of decayed, missing, and filled tooth surfaces (DMFS). Statistical analysis will compare mean DMFS between study groups to generate effect size estimates and standard errors needed to calculate the sample size requirement for a future, multi-site, Phase III RCT.
The investigative team has a strong record of accomplishment in observational and interventional studies of dental caries in children and is experienced in the planning (during the UG3 phase) and conduct (during the 5-year UH3 phase) of the study as required by PAR-18-547. Local, state, and national stakeholders have expressed support for the proposed study, noting its potential to improve oral health in underserved communities.
By applying the rigor of a placebo-controlled RCT design, the study will address a serious shortfall in the evidence that hampers the nation's primary public health strategy for dental caries prevention.
The dental health benefits of fluoride in drinking water have never been tested in a randomized controlled trial (RCT). Instead, the addition of fluoride to many public water systems during the 20th century and the defense against fluoridation's critics were justified based on results from observational studies and a few non-randomized, community intervention studies. However, the growth in fluoridated public water systems has stalled, leaving 100 million Americans living in places without fluoridated water, which is unlikely to change.
Another issue is that nationwide, 15% of children do not drink tap water for various reasons, including consumer preference and distrust of public water. One potential solution is to increase the consumption of fluoridated bottled water, capitalizing on consumers' demand for it. However, for public health to embrace this strategy as an extension of fluoridation, there needs to be RCT evidence of the dental health benefits of fluoridated bottled water.
Given the absence of a precedent and uncertainty regarding compliance and the likely effect size of the intervention, a fully powered RCT is premature. Instead, we propose a Phase II, proof-of-concept RCT to evaluate the dental caries preventive effects of fluoridated bottled water in a community not served by water fluoridation. The primary recruitment population will be approximately 470 babies born during a one-year period in Kinston, NC, which has the largest non-fluoridated public water system in the state and where caries prevalence exceeds the state average.
In households where the measured content of fluoride in tap water is less than 0.2 ppm, we will randomize 200 infant/family dyads in a 1:1 ratio to receive either fluoridated or non-fluoridated bottled water. The two types of commercially available water in 5-gallon bottles will be relabeled to mask the fluoride content from infants, families, and researchers. For 3½ years after randomization, each household will be provided with water, dispensers, and other supplies to encourage water consumption consistent with nutritional recommendations. Bottled water consumption will be monitored, and fingernail clippings will be collected to provide a biomarker measure of fluoride intake.
A dental examination conducted when children are aged 48-53 months will measure caries experience using the index of decayed, missing, and filled tooth surfaces (DMFS). Statistical analysis will compare mean DMFS between study groups to generate effect size estimates and standard errors needed to calculate the sample size requirement for a future, multi-site, Phase III RCT.
The investigative team has a strong record of accomplishment in observational and interventional studies of dental caries in children and is experienced in the planning (during the UG3 phase) and conduct (during the 5-year UH3 phase) of the study as required by PAR-18-547. Local, state, and national stakeholders have expressed support for the proposed study, noting its potential to improve oral health in underserved communities.
By applying the rigor of a placebo-controlled RCT design, the study will address a serious shortfall in the evidence that hampers the nation's primary public health strategy for dental caries prevention.
Funding Goals
NIDCR EXTRAMURAL RESEARCH PROVIDES RESEARCH FUNDS TO SUPPORT BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH IN DENTAL, ORAL, AND CRANIOFACIAL HEALTH AND DISEASE THROUGH GRANTS, COOPERATIVE AGREEMENTS, AND CONTRACTS THAT SUPPORT SCIENTISTS WORKING IN INSTITUTIONS THROUGHOUT THE UNITED STATES AND INTERNATIONALLY. EXTRAMURAL PROGRAMS PLAN, DEVELOP, AND MANAGE SCIENTIFIC PRIORITIES THROUGH PORTFOLIO ANALYSES AND CONSULTATION WITH STAKEHOLDERS, ENCOURAGING THE MOST PROMISING DISCOVERIES AND EMERGING TECHNOLOGIES FOR RAPID TRANSLATION TO CLINICAL APPLICATIONS. THE INTEGRATIVE BIOLOGY AND INFECTIOUS DISEASES PROGRAMS SUPPORTS BASIC AND TRANSLATIONAL RESEARCH PROGRAMS ON ORAL MICROBIOLOGY, SALIVARY BIOLOGY AND IMMUNOLOGY, ORAL AND SALIVARY GLAND CANCERS, NEUROSCIENCE OF OROFACIAL PAIN AND TEMPOROMANDIBULAR DISORDERS, MINERALIZED TISSUE PHYSIOLOGY, DENTAL BIOMATERIALS, AND TISSUE ENGINEERING AND REGENERATIVE MEDICINE. THE BRANCH AIMS TO ACCELERATE PROGRESS IN BASIC AND TRANSLATIONAL RESEARCH IN THESE AREAS, AND FURTHER STIMULATE THE DISCOVERY PIPELINE BASED ON CLINICAL NEEDS. THE TRANSLATIONAL GENOMICS RESEARCH PROGRAMS SUPPORTS BASIC AND TRANSLATIONAL RESEARCH IN GENETICS, GENOMICS, DEVELOPMENTAL BIOLOGY, AND DATA SCIENCE TOWARD THE GOAL OF IMPROVING DENTAL, ORAL, AND CRANIOFACIAL HEALTH. THE FOCUS IS ON DECIPHERING THE GENETIC, MOLECULAR, AND CELLULAR MECHANISMS UNDERLYING DENTAL, ORAL, AND CRANIOFACIAL DEVELOPMENT AND ANOMALIES. THE BEHAVIORAL AND SOCIAL SCIENCES RESEARCH PROGRAMS SUPPORTS BASIC AND APPLIED RESEARCH TO PROMOTE ORAL HEALTH, TO PREVENT ORAL DISEASES AND RELATED DISABILITIES, AND TO IMPROVE MANAGEMENT OF CRANIOFACIAL CONDITIONS, DISORDERS, AND INJURY. THE PROGRAM PRIORITIZES MECHANISTIC RESEARCH THAT CONTRIBUTES TO A CUMULATIVE SCIENCE OF BEHAVIOR CHANGE, TO MAXIMIZE THE RIGOR, RELEVANCE, AND DISSEMINATION OF EFFICACIOUS BEHAVIOR CHANGE INTERVENTIONS. THE CLINICAL RESEARCH PROGRAMS SUPPORTS PATIENT-ORIENTED, POPULATION, AND COMMUNITY BASED RESEARCH AIMED AT IMPROVING THE DENTAL, ORAL, AND CRANIOFACIAL HEALTH OF THE NATION. THE CENTER FOCUSES ON A VARIETY OF DISEASES AND CONDITIONS THROUGH CLINICAL TRIALS, EPIDEMIOLOGIC STUDIES, PRACTICE-BASED RESEARCH, THE HIV/AIDS AND ORAL HEALTH PROGRAM, AND STUDIES OF ORAL HEALTH DISPARITIES AND INEQUITIES IN ALL AREAS OF NIDCR PROGRAMMATIC INTEREST. THE PROGRAM ENCOURAGES INVESTIGATIONS THAT HAVE THE POTENTIAL TO TRANSLATE FINDINGS INTO EVIDENCE-BASED CLINICAL APPLICATIONS. THE RESEARCH TRAINING AND CAREER DEVELOPMENT EXTRAMURAL PROGRAMS SPAN THE CAREER STAGES OF SCIENTISTS, SUPPORTING RESEARCH TRAINING AND CAREER DEVELOPMENT FOR PHD AND DUAL DEGREE DDS/DMD-PHD STUDENTS, POSTDOCTORAL SCHOLARS, AND EARLY CAREER, MIDCAREER, AND ESTABLISHED INVESTIGATORS. THE PROGRAMS MANAGE SUPPORT FOR FELLOWSHIPS, RESEARCH TRAINING GRANTS, CAREER DEVELOPMENT AND CAREER TRANSITION AWARDS, NIH LOAN REPAYMENT AWARDS, AND DIVERSITY SUPPLEMENTS TO SUPPORT RESEARCH EXPERIENCES FOR HIGH SCHOOL STUDENTS THROUGH INVESTIGATORS. NIDCR PARTICIPATES IN THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) AND SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS. THE SBIR PROGRAM IS INTENDED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.THE STTR PROGRAM IS INTENDED TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. EXTRAMURAL PROGRAMS ARE ACCOUNTABLE FOR THE EFFICIENT AND EFFECTIVE USE OF TAXPAYER FUNDS TO SUPPORT RESEARCH ON DENTAL, ORAL, AND CRANIOFACIAL DISEASES AND DISORDERS AND IMPROVING THE ORAL HEALTH OF ALL AMERICANS. EXTRAMURAL PROGRAMS SUPPORT RESEARCH AND RESEARCH TRAINING TO ESTABLISH THE FOUNDATION FOR SCIENTIFIC DISCOVERIES THAT INCLUDE TRANSPARENT AND RIGOROUS PLANNING, PRIORITY SETTING, CONTINUOUS AND CONSISTENT REVIEWS OF PROGRESS, AND FOCUS ON THE DEVELOPMENT OF A DIVERSE, HIGHLY SKILLED, AND NIMBLE WORKFORCE THAT CAN RAPIDLY RESPOND TO SCIENTIFIC BREAKTHROUGHS AND PUBLIC HEALTH CHALLENGES. EXTRAMURAL PROGRAMS ARE ACCOUNTABLE FOR THE EFFICIENT AND EFFECTIVE USE OF TAXPAYER FUNDS TO SUPPORT RESEARCH ON DENTAL, ORAL, AND CRANIOFACIAL DISEASES AND EMPLOY EVALUATION DOMAINS, FROM NEEDS ASSESSMENT AND STRATEGIC PLANNING TO IMPLEMENTATION AND PROCESS EVALUATION, PERFORMANCE MEASUREMENT, AND OUTCOMES AND IMPACT ANALYSIS TO EVALUATE STRATEGIC OBJECTIVES
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Chapel Hill,
North Carolina
27599
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 423% from $1,049,156 to $5,485,200.
University Of North Carolina At Chapel Hill was awarded
Fluoridated Bottle Water RCT for Dental Caries Prevention
Cooperative Agreement UH3DE029169
worth $5,485,200
from the National Institute of Dental and Craniofacial Research in September 2021 with work to be completed primarily in Chapel Hill North Carolina United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.121 Oral Diseases and Disorders Research.
The Cooperative Agreement was awarded through grant opportunity NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required.
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
9/17/21
Start Date
9/16/26
End Date
Funding Split
$5.5M
Federal Obligation
$0.0
Non-Federal Obligation
$5.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UH3DE029169
Transaction History
Modifications to UH3DE029169
Additional Detail
Award ID FAIN
UH3DE029169
SAI Number
UH3DE029169-3678477244
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NP00 NIH National Institute of Dental & Craniofacial Research
Funding Office
75NP00 NIH National Institute of Dental & Craniofacial Research
Awardee UEI
D3LHU66KBLD5
Awardee CAGE
4B856
Performance District
NC-04
Senators
Thom Tillis
Ted Budd
Ted Budd
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Dental and Craniofacial Research, National Institutes of Health, Health and Human Services (075-0873) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,104,773 | 100% |
Modified: 8/6/25